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Abstract
Introduction: Diabetic keratopathy is a rare complication of diabetes mellitus. This case illustrates the importance
of checking blood sugar levels of patients with non-healing corneal ulcers to rule out the possibility of
undiagnosed diabetes mellitus.
Case presentation: We report the unusual case of a 24-year-old southeast Asian woman who presented with a
sterile corneal ulcer to our hospital and later was found to be diabetic after a prolonged hospital stay. Despite all
efforts, the corneal ulcer had failed to heal until treatment for previously undiagnosed diabetes was started. The
sterile corneal ulcer began to heal once blood sugar levels began to normalize.
Conclusions: Diabetic keratopathy is a rare complication of diabetes mellitus and needs to be considered as a
diagnosis in younger patients with non-healing sterile corneal ulcers. Blood sugar levels should be checked in
these cases for undiagnosed diabetes mellitus.
Introduction
We report an unusual case of a 24-year-old southeast
Asian woman who presented with a sterile corneal ulcer
to our hospital and later was found to be diabetic. Her
corneal ulcer had failed to heal until her blood sugar
levels began to normalize. Diabetic keratopathy is a rare
complication of diabetes mellitus and needs to be con-
sidered as a diagnosis in younger patients with non-
healing sterile corneal ulcers. In a previous publication,
a 44-year-old man presented in a similar fashion,
although in that instance the condition was bilateral [1].
The case in our report highlights the importance of
investigating patients who present with unexplained cor-
neal ulceration to exclude undiagnosed diabetes
mellitus.
Case presentation
A 24-year-old southeast Asian woman was admitted
with a history of a white spot on the right cornea and
increasing discomfort. On examination, her vision was
6/36 on the right and 6/9 on the left. She had a corneal
ulcer measuring 5.5 × 2 mm on her right cornea. A
small localized area of scarring was present lateral to
where the defect was present (Figure 1). There was a +1
cell reaction in her right anterior chamber. She had a
history of bilateral anterior uveitis. Corneal sensation
was normal in both eyes. There were early bilateral pos-
terior subcapsular cataracts.
In view of the findings, corneal scrapes were taken for
microscopy, culture, and sensitivity. Virology assays
inclusive of herpes simplex virus and varicella-zoster
virus polymerase chain reaction were performed. Our
patient had normal C-reactive protein, rheumatoid fac-
tor, anti-nuclear antibody, extractable nuclear antigen,
syphilis, and hepatitis B and C serology. She was started
on topical g. cephalothin 5% and g. gentamicin 0.9%
hourly for 48 hours. She made a mild initial improve-
ment and was changed to topical g. chloramphenicol 1%
four times each day and g. prednisolone 0.5% four times
each day once her microbiology and virology results
were negative. A bandage contact lens was inserted to
facilitate healing (Figure 2).
In the third week of admission, she complained of a
headache and was found to be mildly tachycardic. She
was apyrexial with no reported malaise. A urinary dip-
stick analysis was performed, and her urinary glucose
level was 21 mmol/L. Blood glucose was urgently
requested and was found to be 23 mmol/L. A blood gas
analysis showed a pH of 7.38, a partial pressure of
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pressure of oxygen (pO2) of 89.5 mmHg.
She was transferred to the care of the medical team
and a diagnosis of type 1 diabetes was made. She was
started on treatment with insulin. Her corneal ulcer per-
sisted and punctal plugs were inserted to increase the
tear film and facilitate healing. Autologous serum drops
were started every two hours during waking hours.
There was a rapid reduction of the epithelial defect as
her blood glucose levels normalized (Figure 3).
Four days after insulin treatment was started, her
ulcer had healed and she was discharged from the hos-
pital and follow-up was conducted at her local diabetes
clinic. At a one-month review in the eye clinic, her
ulcer remained healed, leaving a localized area of sube-
pithelial scarring (Figure 4).
Discussion
The ocular features of diabetes mellitus have been
described in other reports. Impaired glucose metabolism
typically results in a localized microangiopathy that
affects primarily the retinal vasculature and that pro-
duces the classic lesions in the fundus with microaneur-
ysms, intraretinal hemorrhages, exudation, and new
vessel formation [2]. A combination of good glycemic
control and regular visits to the eye clinic can often
slow or halt the progression of the disease.
Diabetic keratopathy is a rare complication of the con-
dition. In this setting, impaired epithelial healing is
thought to be a consequence of an abnormal aldose
reductase pathway and secondary accumulation of
polyol within the epithelial and endothelial cells and
thus result in cellular dysfunction [3,4]. This results in
Figure 1 Color photograph of the right eye shows the ulcer
and an area of paracentral intrastromal scarring.
Figure 2 Cobalt blue photograph of the right eye.F l u o r e s c e i n
dye was used to highlight the large central ulcer (green stain).
Figure 3 Cobalt blue photograph of the right eye shows a
smaller ulcer (green stain). The ulcer began to heal rapidly once
insulin treatment was initiated.
Figure 4 Color photograph of the right eye at one month.T h e
defect has healed, leaving a diffuse area of scarring.
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to the basement membrane, increasing the risk of recur-
rent corneal erosions. Minor trauma and ocular manipu-
lation with contact lenses can also produce chronic non-
healing defects [5]. Our patient had no history of trauma
or contact lens use. Other ocular features of diabetes
mellitus include reduced corneal sensation and tear pro-
duction and basement membrane thickening [5-7].
It is important when considering the diagnosis of dia-
betic keratopathy to exclude other treatable causes of
non-healing defects, such as anterior basement mem-
brane dystrophy and recurrent erosion syndrome. Treat-
ment options in cases of a persistent ulceration include
the use of frequent lubrication, bandage contact lenses,
topical autologous serum drops, and patching. If conser-
vative measures fail, it may be necessary to perform
temporary tarsorrhaphy to facilitate healing.
Other conditions that delay epithelial healing need to
be identified and treated accordingly. Hence, coexisting
neurotrophic keratopathy needs to be excluded by a
careful assessment of corneal sensation. Dry eye disease
can also delay healing and can be identified with rose-
bengal staining of the cornea and conjunctiva and use of
the Schirmer test. Nocturnal lagophthalmos needs to be
managed with appropriate nocturnal padding and
lubrication.
Animal studies have shown that the opioid antagonist
naltrexone and insulin used topically can facilitate heal-
ing in diabetic rats by enhancing DNA synthesis and re-
epithelialization through alterations in local opioid
growth factors [8,9]. In the future, these agents may be
approved for use in the treatment of diabetic
keratopathy.
Conclusions
Four days after insulin treatment was started, our
patient’s ulcer had healed and she was discharged from
the hospital and follow-up was arranged at her local dia-
betes clinic. The diagnosis of diabetes mellitus was thus
made somewhat incidentally. Our patient did not report
weight loss, polyuria, or polydipsia to facilitate the diag-
nosis of diabetes, and her only complaint was a brief
history of headaches while in the hospital. Her urinary
glucose level was checked as part of an investigation for
transient tachycardia and elevated glucose levels were
detected.
Using a combination of a bandage contact lens, tem-
porary punctal plugs, and autologous serum drops
proved useful in facilitating ulcer healing. Although the
corneal ulcer showed initial signs of healing, it was after
the blood sugar levels began to normalize that the ulcer
fully healed.
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